Oxford Expression Technologies Launches baculoCOMPLETE™

Oxford Expression Technologies, the award-winning specialist provider of baculovirus-based protein expression solutions, launches its new baculoCOMPLETE™ kit

Oxford, UK, July 18, 2011 - Oxford Expression Technologies, the award-winning specialist provider of baculovirus-based protein expression solutions, launches its new baculoCOMPLETE™ kit, the all-in-one baculovirus expression kit. The new kit contains all the necessary components for the expression of recombinant proteins in insect cells in a single pack and each kit is capable of producing five recombinant viruses.

As well as containing all of the necessary components for recombinant protein expression, the baculoCOMPLETE™ kit also contains a user guide listing step by step instructions on how to use each component for reproducible high yield recombinant protein production. To cater for new users, an overview on insect cell culture and baculovirus protein expression is also included to complete the all-in-one package.

Passing comment, Richard Broadhead, Sales and Marketing Manager at Oxford Expression Technologies said, “The launch of the baculoCOMPLETE™ all-in-one baculovirus expression kit represents our commitment to provide ease of use to our users and scientists involved in protein expression,” he continued, “Due to the all-in-one nature and informative aspects of the kit, it provides an excellent opportunity and platform for users of other expression systems to easily adopt and benefit from the advantages of baculovirus protein expression.”

Oxford Expression Technologies invites anyone with an interest in baculovirus protein expression to visit their website - http://oetltd.com/

Oxford Expression Technologies is a biotechnology company specializing in the use of baculovirus vectors, a eukaryotic expression system that can express a large variety of recombinant proteins. Oxford Expression Technologies provides protein expression products, services and consultancy to many global pharmaceutical companies. The Company’s proprietary flashBAC technology enables large amounts of a given protein to be produced in culture. Its internationally renowned expertise and products enable proteins to be produced faster, more easily and cost-effectively using automated and high-throughput methods compared with other baculovirus expression systems. This contributes to the development of new drugs and research targeted towards understanding how proteins work in health and disease.

The company was founded in 2007 as a result of collaboration between Oxford Brookes University and the Natural Environment Research Council to provide researchers with custom proteins for research purposes.

Contact:
Mathew Taylor
Director
Algorythm Solutions Ltd
10 Torkington St
Stamford, Lincolnshire PE9 2UY
+44 (0)773 403 2112
mtaylor@algorythmsolutions.com
http://www.algorythmsolutions.com

This release was published on openPR.